Literature DB >> 8443137

Induction of murine macrophage growth by modified LDLs.

S Yui1, T Sasaki, A Miyazaki, S Horiuchi, M Yamazaki.   

Abstract

We previously reported that cell membrane components and lipoproteins were able to induce the growth of murine peritoneal macrophages. The aim of the present study was to examine whether macrophage growth could also be induced by chemically modified lipoproteins, such as acetylated low density lipoprotein (acetyl-LDL) or oxidized LDL, ligands known to be endocytosed by the macrophage scavenger receptors. When murine peritoneal exudate macrophages were cultured in vitro with 25-100 micrograms/mL acetyl-LDL or oxidized LDL, significant growth was induced. On comparing the dose-response curves of these LDLs, a more potent effect was seen with oxidized LDL than acetyl-LDL, especially on resident macrophages. On the other hand, growth of these cells was not stimulated by native (unmodified) LDL or high density lipoprotein. These in vitro data revealed a new function of chemically modified LDLs as effective inducers of macrophage cell growth. This aspect may be physiologically relevant to the growth of macrophage foam cells in situ in the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443137     DOI: 10.1161/01.atv.13.3.331

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  17 in total

1.  Exposure to oxidized low-density lipoprotein reduces activable Ras protein in vascular endothelial cells.

Authors:  Shu-Er Chow; Wing-Keung Chu; Stephen H Shih; Jan-Kan Chen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-06       Impact factor: 2.416

2.  Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesity.

Authors:  A S Kelly; J R Ryder; K L Marlatt; K D Rudser; T Jenkins; T H Inge
Journal:  Int J Obes (Lond)       Date:  2015-08-28       Impact factor: 5.095

3.  Detection of type III collagen fragments in specimens of abdominal aortic aneurysms.

Authors:  T Kuga; K Esato; N Zempo; K Fujioka; K Nakamura
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

Review 4.  Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases.

Authors:  Jia-Ming Xu; Guo-Ping Shi
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

5.  Enhancement of macrophage survival and DNA synthesis by oxidized-low-density-lipoprotein (LDL)-derived lipids and by aggregates of lightly oxidized LDL.

Authors:  J A Hamilton; W Jessup; A J Brown; G Whitty
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

6.  Circulating oxidized LDL and inflammation in extreme pediatric obesity.

Authors:  Anne L Norris; Julia Steinberger; Lyn M Steffen; Andrea M Metzig; Sarah Jane Schwarzenberg; Aaron S Kelly
Journal:  Obesity (Silver Spring)       Date:  2011-02-17       Impact factor: 5.002

7.  Lipoproteins modulate expression of the macrophage scavenger receptor.

Authors:  J Han; A C Nicholson
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

8.  Sphingosine kinase regulates oxidized low density lipoprotein-mediated calcium oscillations and macrophage survival.

Authors:  Johnny H Chen; Maziar Riazy; Shih Wei Wang; Jiazhen Minnie Dai; Vincent Duronio; Urs P Steinbrecher
Journal:  J Lipid Res       Date:  2009-11-05       Impact factor: 5.922

9.  Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease.

Authors:  Ayla Yalamanoglu; Jeremy W Deuel; Ryan C Hunt; Jin Hyen Baek; Kathryn Hassell; Katie Redinius; David C Irwin; Dominik J Schaer; Paul W Buehler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-07-26       Impact factor: 5.464

10.  Arginase I induction by modified lipoproteins in macrophages: a peroxisome proliferator-activated receptor-gamma/delta-mediated effect that links lipid metabolism and immunity.

Authors:  Alejandro Gallardo-Soler; Carlos Gómez-Nieto; María Luisa Campo; Chaitra Marathe; Peter Tontonoz; Antonio Castrillo; Inés Corraliza
Journal:  Mol Endocrinol       Date:  2008-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.